Intensified fractional CO2 laser-assisted photodynamic therapy vs. laser alone for organ transplant recipients with multiple actinic keratoses and wart-like lesions: A randomized half-side comparative trial on dorsal hands

British Journal of Dermatology

Volumn 169, Issue 5, 2013, Pages 1087-1092

  Helsing, P ^a   Togsverd Bo, K ^b   Veierod M B ^c   Mork G ^a   Haedersdal M ^b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID METHYL ESTER;

ACTINIC KERATOSIS; ADULT; AGED; ARTICLE; CARBON DIOXIDE LASER; CLINICAL ARTICLE; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DERMATITIS; DISEASE SEVERITY; ERYTHEMA; FEMALE; GRAFT RECIPIENT; HAND; HEART GRAFT; HUMAN; KIDNEY GRAFT; LASER SURGERY; LIVER GRAFT; MALE; MONOTHERAPY; PATIENT ASSESSMENT; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PURPURA; RANDOMIZED CONTROLLED TRIAL; SKIN DEFECT; SKIN EDEMA; SKIN PAIN; SKIN PIGMENTATION; TREATMENT RESPONSE; WART LIKE LESION; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; GAS LASER; HAND DISEASE; METHODOLOGY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; ORGAN TRANSPLANTATION; PHOTOCHEMOTHERAPY; POSTOPERATIVE COMPLICATION; TREATMENT OUTCOME; VERRUCA VULGARIS;

AGED; COMBINED MODALITY THERAPY; FEMALE; HAND DERMATOSES; HUMANS; KERATOSIS, ACTINIC; LASERS, GAS; MALE; MIDDLE AGED; ORGAN TRANSPLANTATION; PHOTOCHEMOTHERAPY; POSTOPERATIVE COMPLICATIONS; TREATMENT OUTCOME; WARTS;

EID: 84887051729     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.12507     Document Type: Article

References (24)

1. Jensen P, Hansen S, Møller B, et al,. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol 1999; 40: 177-86.
2. Hartevelt MM, Bavinck JN, Kootte AM, et al,. Incidence of skin cancer after renal transplantation in The Netherlands. Transplantation 1990; 49: 506-9.
3. Krynitz B, Edgren G, Lindelöf B, et al,. Risk of skin cancer and other malignancies in kidney, liver, heart and lung transplant recipients 1970 to 2008-a Swedish population-based study. Int J Cancer 2012; 132: 1429-38.
4. Buell JF, Gross TG, Woodle ES,. Malignancy after transplantation. Transplantation 2005; 80: S254-64.
5. Zwald FO, Brown M,. Skin cancer in solid organ transplant recipients: advances in therapy and management: part II. Management of skin cancer in solid organ transplant recipients. J Am Acad Dermatol 2011; 65: 263-79.
6. Morton CA, Szeimies RM, Sidoroff A, Braathen LR,. European guidelines for topical photodynamic therapy part 2: emerging indications-field cancerization, photorejuvenation and inflammatory/infective dermatoses. J Eur Acad Dermatol Venereol 2013; 27: 672-9.
7. Basset-Seguin N, Baumann Conzett K, Gerritsen MJ, et al,. Photodynamic therapy for actinic keratosis in organ transplant patients. J Eur Acad Dermatol Venereol 2013; 27: 57-66.
8. Dragieva G, Hafner J, Dummer R, et al,. Topical photodynamic therapy in the treatment of actinic keratoses and Bowen's disease in transplant recipients. Transplantation 2004; 77: 115-21.
9. Piaserico S, Belloni Fortina A, Rigotti P, et al,. Topical photodynamic therapy of actinic keratosis in renal transplant recipients. Transplant Proc 2007; 39: 1847-50.
10. Dragieva G, Prinz BM, Hafner J, et al,. A randomized controlled clinical trial of topical photodynamic therapy with methyl aminolaevulinate in the treatment of actinic keratoses in transplant recipients. Br J Dermatol 2004; 151: 196-200.
11. Tyrrell JS, Morton C, Campbell SM, Curnow A,. Comparison of protoporphyrin IX accumulation and destruction during methylaminolevulinate photodynamic therapy of skin tumours located at acral and nonacral sites. Br J Dermatol 2011; 164: 1362-8.
12. Hantash BM, Stewart DB, Cooper ZA, et al,. Facial resurfacing for non-melanoma skin cancer prophylaxis. Arch Dermatol 2006; 142: 976-82.
13. Wollina U, Konrad H, Karamfilov T,. Treatment of common warts and actinic keratoses by Er:YAG laser. J Cutan Laser Ther 2001; 3: 63-6.
14. Prens SP, Vries KD, Neumann HA, Prens EP,. Non-ablative fractional resurfacing in combination with topical tretinoin cream as a field treatment modality for multiple actinic keratosis: a pilot study and a review of other field treatment modalities. J Dermatolog Treat 2013; 24: 227-31.
15. 2 laser-assisted drug delivery. Lasers Surg Med 2010; 42: 113-22.
16. 2 laser pretreatment. Lasers Surg Med 2011; 43: 804-13.
17. 2 laser: a randomized clinical trial. Br J Dermatol 2012; 166: 1262-9.
18. Olsen EA, Abernethy ML, Kulp-Shorten C, et al,. A double-blind, vehicle-controlled study evaluating masoprocol cream in the treatment of actinic keratoses on the head and neck. J Am Acad Dermatol 1991; 24: 738-43.
19. Boyd AS, Stasko T, Cameron GS, et al,. Histologic features of keratoses in solid organ transplant recipients and healthy controls. J Am Acad Dermatol 2001; 45: 217-21.
20. Gerritsen MJ, Smits T, Kleinpenning MM, et al,. Pretreatment to enhance protoporphyrin IX accumulation in photodynamic therapy. Dermatology 2009; 218: 193-202.
21. Bencini PL, Galimberti MG, Pellacani G, Longo C,. Application of photodynamic therapy combined with pre-illumination microneedling in the treatment of actinic keratosis in organ transplant recipients. Br J Dermatol 2012; 167: 1193-4.
22. Lindeburg KE, Brogaard HM, Jemec GB,. Pain and photodynamic therapy. Dermatology 2007; 215: 206-8.
23. Wiegell SR, Wulf HC, Szeimies RM, et al,. Daylight photodynamic therapy for actinic keratosis: an international consensus: International Society for Photodynamic Therapy in Dermatology. J Eur Acad Dermatol Venereol 2012; 26: 673-9.
24. Wiegell SR, Haedersdal M, Eriksen P, Wulf HC,. Photodynamic therapy of actinic keratoses with 8% and 16% methyl aminolaevulinate and home-based daylight exposure: a double-blinded randomized clinical trial. Br J Dermatol 2009; 160: 1308-14.